I was pretty happy to read that they are cutting off all non-essential projects. they already have a lot in the works and the current focus should be on building revenue which is what those statements appears to be alluding too. Again disappointed with staff costs especially when compared to Zelda.
CannEpil is the key focus in my view. If we see positive news on that in the next few weeks the SP will rise. Varm is still a faint possibility but the constant delays have soured this deal. Regardless of whether Varm goes through or not I am expecting significant revenue before the end of CY.
I was pretty happy to read that they are cutting off all...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.58M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 31.0¢ | 30.0¢ | $2.567K | 8.41K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 47481 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 8026 | 2 |
View Market Depth
| Last trade - 15.53pm 21/06/2024 (20 minute delay) ? |
| RGT (ASX) Chart |